Israel Englander Moon Lake Immunotherapeutics Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2024 May 15, 2024	SELL	$43.78 - $63.86 $744,260 - $1.09 Million	-17,000 Reduced 62.5%	10,200 $512,000
Q4 2023 Feb 14, 2024	BUY	$36.35 - $63.02 $988,720 - $1.71 Million	27,200 New	27,200 $1.64 Million

127

58M

103K

79.7K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $2B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.